Macroview Investment Management’s Medical Properties Trust MPT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-1,936
| Closed | -$9.1K | – | 657 |
|
|
2024
Q1 | $9.1K | Buy |
1,936
+105
| +6% | +$402 | 0.01% | 262 |
|
|
2023
Q4 | $8.99K | Hold |
1,831
| – | – | 0.01% | 275 |
|
|
2023
Q3 | $9.98K | Buy |
1,831
+26
| +1% | +$208 | 0.01% | 267 |
|
|
2023
Q2 | $16.7K | Buy |
1,805
+57
| +3% | +$482 | 0.03% | 146 |
|
|
2023
Q1 | $14.4K | Buy |
1,748
+109
| +7% | +$1.2K | 0.02% | 157 |
|
|
2022
Q4 | $18.3K | Buy |
+1,639
| New | +$19.1K | 0.03% | 140 |
|
|
2022
Q3 | – | Sell |
-126
| Closed | -$2K | – | 474 |
|
|
2022
Q2 | $2K | Hold |
126
| – | – | ﹤0.01% | 374 |
|
|
2022
Q1 | $3K | Buy |
126
+2
| +2% | +$43 | ﹤0.01% | 338 |
|
|
2021
Q4 | $3K | Buy |
124
+1
| +0.8% | +$21 | ﹤0.01% | 308 |
|
|
2021
Q3 | $2K | Hold |
123
| – | – | ﹤0.01% | 327 |
|
|
2021
Q2 | $2K | Sell |
123
-22
| -15% | -$471 | ﹤0.01% | 351 |
|
|
2021
Q1 | $3K | Sell |
145
-27
| -16% | -$581 | ﹤0.01% | 297 |
|
|
2020
Q4 | $4K | Buy |
172
+2
| +1% | +$39 | 0.01% | 229 |
|
|
2020
Q3 | $3K | Buy |
170
+2
| +1% | +$37 | 0.01% | 221 |
|
|
2020
Q2 | $3K | Sell |
168
-372
| -69% | -$6.59K | 0.01% | 203 |
|
|
2020
Q1 | $9K | Sell |
540
-650
| -55% | -$13.6K | 0.02% | 123 |
|
|
2019
Q4 | $25K | Sell |
1,190
-400
| -25% | -$8.1K | 0.05% | 101 |
|
|
2019
Q3 | $31K | Buy |
+1,590
| New | +$29.2K | 0.07% | 83 |
|
|
2019
Q2 | – | Hold |
0
| – | – | – | 90 |
|
|
2019
Q1 | – | Sell |
-2,511
| Closed | -$44.8K | – | 94 |
|
|
2018
Q4 | $40K | Hold |
2,511
| – | – | 0.13% | 77 |
|
|
2018
Q3 | $37K | Sell |
2,511
-1,495
| -37% | -$21.8K | 0.12% | 78 |
|
|
2018
Q2 | $56K | Buy |
4,006
+5
| +0.1% | +$66 | 0.2% | 58 |
|
|
2018
Q1 | $52K | Sell |
4,001
-3,195
| -44% | -$40.9K | 0.19% | 56 |
|
|
2017
Q4 | $99K | Buy |
7,196
+4
| +0.1% | +$54 | 0.47% | 29 |
|
|
2017
Q3 | $94K | Buy |
7,192
+5
| +0.1% | +$64 | 0.47% | 30 |
|
|
2017
Q2 | $92K | Buy |
7,187
+5
| +0.1% | +$67 | 0.5% | 21 |
|
|
2017
Q1 | $93K | Sell |
7,182
-16,924
| -70% | -$216K | 0.54% | 21 |
|
|
2016
Q4 | $297K | Sell |
24,106
-5,899
| -20% | -$76.3K | 1.62% | 16 |
|
|
2016
Q3 | $443K | Sell |
30,005
-5,914
| -16% | -$89.5K | 1.97% | 14 |
|
|
2016
Q2 | $546K | Sell |
35,919
-16,364
| -31% | -$232K | 2.42% | 13 |
|
|
2016
Q1 | $679K | Sell |
52,283
-68,181
| -57% | -$778K | 2.94% | 13 |
|
|
2015
Q4 | $1.39M | Sell |
120,464
-231,493
| -66% | -$2.64M | 4.43% | 8 |
|
|
2015
Q3 | $3.89M | Buy |
351,957
+99,711
| +40% | +$1.24M | 7.11% | 5 |
|
|
2015
Q2 | $3.31M | Sell |
252,246
-5,794
| -2% | -$80.8K | 3.75% | 11 |
|
|
2015
Q1 | $3.8M | Buy |
258,040
+25,304
| +11% | +$376K | 3.54% | 7 |
|
|
2014
Q4 | $3.21M | Buy |
232,736
+67,378
| +41% | +$903K | 3.36% | 12 |
|
|
2014
Q3 | $2.03M | Buy |
165,358
+2,912
| +2% | +$38.7K | 2.72% | 14 |
|
|
2014
Q2 | $2.15M | Buy |
162,446
+74,421
| +85% | +$988K | 2.86% | 16 |
|
|
2014
Q1 | $1.13M | Buy |
+88,025
| New | +$1.13M | 1.71% | 23 |
|
Other funds holding MPT
Macroview Investment Management's MPT Position: Q2 2024 in Review
Macroview Investment Management sold out of Medical Properties Trust (MPT) in Q2 2024, closing a stake of 1,936 shares — an estimated $9.1K sold.
Macroview Investment Management first reported a position in MPT in Q1 2014 and held it in 38 quarters. The position peaked at $3.89M in Q3 2015. 500 funds tracked by Wall St. Rank hold MPT as of Q2 2024.
- Macroview Investment Management reported no remaining Medical Properties Trust position as of Q2 2024 after selling out during the quarter.
- Macroview Investment Management sold 1,936 Medical Properties Trust shares in Q2 2024, an estimated $9.1K.
- Macroview Investment Management first reported a position in Medical Properties Trust in Q1 2014 and held it in 38 quarters.
- Macroview Investment Management's Medical Properties Trust position peaked at $3.89M in Q3 2015.
- 500 funds tracked by Wall St. Rank held Medical Properties Trust as of Q2 2024.
Based on Macroview Investment Management's 13F filing for Q2 2024, filed 23 Jul 2024.